SEARCH

SEARCH BY CITATION

References

  • 1
    Hou J, Liu Z, Gu F: Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005; 2:5058
  • 2
    Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hep 2004; 2:97107
  • 3
    Nick S, Scheiblauer H: Sensitivities of CE-Marked HIV, HCV, and HBsAg Assays. J Med Virol 2007; 79:S59S64
  • 4
    Scheiblauer H, Soboll H, Nick S: Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol 2006; 78(S1):S66S70
  • 5
    Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R: The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 1997; 26:16581666
  • 6
    European Union: Commission Decision of 3 February 2009 on common technical specifications for in vitro-diagnostic medical devices 2002/364/EC. Official Journal of the European Communities 2009; L39/34L39/49
  • 7
    Food and Drug Administration (FDA), U.S. Guidance for Industry: Adequate and appropriate donor screening tests for hepatitis B; hepatitis B surface antigen (HBsAg) assays used to test blood, blood components, including source plasma and source leukocytes. November 2007; http://www.fda.gov/cber/gdlns/hbslotrel.pdf
  • 8
    Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336:325329
  • 9
    Coleman PF, Chen YCJ, Mushahwar IK: Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999; 58:1924
  • 10
    Weinberger KM, Bauer T, Böhm S, Jilg W: High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81:11651174
  • 11
    Purdy MA: Hepatits B virus S gene escape mutants. Asian J Transf Sci 2007; 1:6270
  • 12
    Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M: Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988; 69:25752583
  • 13
    Norder H, Courouce AM, Magnius LO: Molecular basis of hepatitis B virus serotype variations within four major subtypes. J Gen Virol 1992; 73:31413145
  • 14
    Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, Magnius LO: Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993; 74:13411348
  • 15
    Norder H, Courouce AM, Magnius LO: Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virol 1994; 198:489503
  • 16
    Sugauchi F, Orito E, Kato H, Suzuki S, Kawakita S, Sakamoto Y, Fukushima K, Akiba T, Yoshihara N, Ueda R, Mizokami M: Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus. J Med Virol 2003; 69:3340
  • 17
    Miyakawa Y, Mizokami M: Classifying hepatitis B virus genotypes. Intervirology 2003; 46:329338
  • 18
    Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO: Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47:289309
  • 19
    Purdy MA, Talekar G, Swenson P, Araujo A, Fields H: A new algorithm for deduction of hepatitis B surface antigen subtype determinants from the amino acid sequence. Intervirology 2007; 50:4551
  • 20
    Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R: A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000; 81:6774
  • 21
    Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO: Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002; 83:20592073
  • 22
    World Health Organization (WHO): WHO Consultation on Global Measurement Standards and their use in the in vitro Biological Diagnostic Field. Geneva, Switzerland 7–8 June 2004: http://www.who.int/bloodproducts/publications/en/Minutes-220804.pdf
  • 23
    Gerlich W, Thomssen R: Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume. Develop Biol Standard 1975; 30:7887
  • 24
    International Consortium for Blood Safety (ICBS), New York, USA & ICBS-Europe, Düsseldorf, Germany: HBV test kit evaluation results; http://www.icbs-web.org/page31.html
  • 25
    Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S: Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998; 143:23132326
  • 26
    Deguchi M, Naoko Y, Masanori K, Seishi A, Yoshinori I, Takahiko T, Kazushige I, Mushahwar IK: Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 2004; 115:217222
  • 27
    Paul-Ehrlich-Institut: Explanations on How to Complete Application Forms for Approval of Test Sera and Test Antigens for the Detection of Viruses, 3rd edn. Langen/Germany, Paul-Ehrlich-Institut, 1999
  • 28
    Clinical and Laboratory Standards Institute (CLSI): Document ILA18-A2: Specifications for Immunological Testing for Infectious Diseases; Approved Guideline, 2nd edn. Wayne, PA, CLSI, 2001. Vol. 21, No. 15
  • 29
    The R Development Core Team: The R Foundation for Statistical Computing; R version 2.8.0, October 20, 2008 (http://www.r-project.org/)
  • 30
    Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group: Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Transfusion 2007; 47:11621171
  • 31
    Lin YH, Wang Y, Loua A, Day GJ, Qiu Y, Nadala EC Jr, Allain JP, Lee HH: Evaluation of a new HBsAg rapid test with improved sensitivity. J Clin Microbiol 2008; 46:33193324
  • 32
    Swenson PD, Van Geyt C, Alexander ER, Hagan H, Freitag-Koontz JM, Wilson S, Norder H, Magnius LO, Stuyver L: Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA. J Med Virol 2001; 64:305311
  • 33
    Ijaz S, Bridget Ferns R, Tedder RS: A ‘first loop’ linear epitope accessible on native hepatitis B surface antigen that persists in the face of ‘second loop’ immune escape. J Gen Virol 2003; 84:269275
  • 34
    Mizuochi T, Okada Y, Umemori K, Mizusawa S, Sato S, Yamaguchi K: Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan. Jpn J Inf Dis 2005; 58:8387
  • 35
    Mizuochi T, Okada Y, Umemori K: Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H. J Virol Methods 2006; 136:254256
  • 36
    Bartholomeusz A, Schäfer S: Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 2004; 14:316
  • 37
    Olinger CM, Weber B, Otegbayo JA, Ammerlaan W, Van Der Taelem-Brulé N, Müller CP: Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene. Med Microbiol Immunol 2007; 196:247252
  • 38
    Weber B, Van Der Taelem-Brulé N, Berger A, Simon F, Geudin M, Ritter J: Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol 2003; 41:135143
  • 39
    Heijtink RA, Van Bergen P, Melber K, Janowicz ZA, Osterhaus ADME: Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination. Vaccine 2002; 20:21912196
  • 40
    Levicnik-Stezinar S: Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin Lab 2004; 50:4951